Research tells us that roughly one in 20 teenagers in the United States suffers from clinical depression. The problem is most are not receiving treatment because they haven't been diagnosed. In a recent report, the US Preventive Services Task Force issued a recommendation for the routine screening of all adolescents in the primary care setting, even if they don't show signs of depression. Is this recommendation practical? And, can our healthcare system accommodate the likely increase in teens who would subsequently become candidates for mental health treatment? Dr. Barry Sarvet, chief of child and adolescent psychiatry at Baystate Medical Center in Springfield, Massachusetts, joins host Dr. Jennifer Shu for a discussion of the pros and cons of routine depression screening for teenagers.
Routine Screening for Depression Among Teens
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Research tells us that roughly one in 20 teenagers in the United States suffers from clinical depression. The problem is most are not receiving treatment because they haven't been diagnosed. In a recent report, the US Preventive Services Task Force issued a recommendation for the routine screening of all adolescents in the primary care setting, even if they don't show signs of depression. Is this recommendation practical? And, can our healthcare system accommodate the likely increase in teens who would subsequently become candidates for mental health treatment? Dr. Barry Sarvet, chief of child and adolescent psychiatry at Baystate Medical Center in Springfield, Massachusetts, joins host Dr. Jennifer Shu for a discussion of the pros and cons of routine depression screening for teenagers.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Updates From the 7th World Symposium Task Force
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
A Practical Guide to Prescribing in HF
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?